Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome

被引:11
|
作者
Careaga, Milo [1 ,2 ,3 ]
Noyon, Tamanna [3 ]
Basuta, Kirin [4 ]
Van de Water, Judy [3 ,5 ]
Tassone, Flora [3 ,4 ]
Hagerman, Randi J. [3 ,6 ]
Ashwood, Paul [1 ,2 ,3 ]
机构
[1] Univ Calif Davis, Dept Med Microbiol & Immunol, Sacramento, CA 95817 USA
[2] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA
[3] Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA
[4] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA USA
[5] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA USA
[6] Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA
来源
JOURNAL OF NEUROINFLAMMATION | 2014年 / 11卷
关键词
Fragile x syndrome; Immune; Cytokine; Metabotropic glutamate receptor; MOUSE MODEL; EXPANDED ALLELES; GENE FMR-1; CGG REPEAT; ACTIVATION; MGLUR5; IDENTIFICATION; INFLAMMATION; PERFORMANCE; PROFILES;
D O I
10.1186/1742-2094-11-110
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Fragile X syndrome (FXS) is the leading cause of inheritable intellectual disability in male children, and is predominantly caused by a single gene mutation resulting in expanded trinucleotide CGG-repeats within the 5' untranslated region of the fragile X mental retardation (FMR1) gene. Reports have suggested the presence of immune dysregulation in FXS with evidence of altered plasma cytokine levels; however, no studies have directly assessed functional cellular immune responses in children with FXS. In order to ascertain if immune dysregulation is present in children with FXS, dynamic cellular responses to immune stimulation were examined. Methods: Peripheral blood mononuclear cells (PBMC) were from male children with FXS (n = 27) and from male aged-matched typically developing (TD) controls (n = 8). PBMC were cultured for 48 hours in media alone or with lipopolysaccharides (LPS; 1 mu g/mL) to stimulate the innate immune response or with phytohemagglutinin (PHA; 8 mu g/mL) to stimulate the adaptive T-cell response. Additionally, the group I mGluR agonist, DHPG, was added to cultures to ascertain the role of mGluR signaling in the immune response in subject with FXS. Supernatants were harvested and cytokine levels were assessed using Luminex multiplexing technology. Results: Children with FXS displayed similar innate immune response following challenge with LPS alone when compared with TD controls; however, when LPS was added in the presence of a group I mGluR agonist, DHPG, increased immune response were observed in children with FXS for a number of pro-inflammatory cytokines including IL-6 (P = 0.02), and IL-12p40 (P < 0.01). Following PHA stimulation, with or without DHPG, no significant differences between subjects with FXS and TD were seen. Conclusions: In unstimulated cultures, subjects with FXS did not display altered dynamic immune response to LPS or PHA alone; however, subjects with FXS showed an altered response to co-current stimulation of LPS and DHPG, such that subjects with FXS failed to inhibit production of pro-inflammatory cytokines, suggesting a role of group I mGluR signaling in innate immune responses in FXS.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain
    Aschrafi, A
    Cunningham, BA
    Edelman, GM
    Vanderklish, PW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (06) : 2180 - 2185
  • [22] Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism
    D'Antoni, Simona
    Spatuzza, Michela
    Bonaccorso, Carmela M.
    Musumeci, Sebastiano A.
    Ciranna, Lucia
    Nicoletti, Ferdinando
    Huber, Kimberly M.
    Catania, Maria Vincenza
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2014, 46 : 228 - 241
  • [23] Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development
    Andreea S. Pop
    Baltazar Gomez-Mancilla
    Giovanni Neri
    Rob Willemsen
    Fabrizio Gasparini
    Psychopharmacology, 2014, 231 : 1217 - 1226
  • [24] Dual Regulation of Fragile X Mental Retardation Protein by Group I Metabotropic Glutamate Receptors Controls Translation-Dependent Epileptogenesis in the Hippocampus
    Zhao, Wangfa
    Chuang, Shih-Chieh
    Bianchi, Riccardo
    Wong, Robert K. S.
    JOURNAL OF NEUROSCIENCE, 2011, 31 (02) : 725 - 734
  • [25] Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse
    Valenti, O
    Marino, MJ
    Wittmann, M
    Lis, E
    DiLella, AG
    Kinney, GG
    Conn, PJ
    JOURNAL OF NEUROSCIENCE, 2003, 23 (18) : 7218 - 7226
  • [26] Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease
    Ribeiro, Fabiola M.
    Paquet, Maryse
    Cregan, Sean P.
    Ferguson, Stephen S. G.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (05) : 574 - 595
  • [27] Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics
    Walker, Adam G.
    Conn, P. Jeffrey
    CURRENT OPINION IN PHARMACOLOGY, 2015, 20 : 40 - 45
  • [28] Fragile X mental retardation protein (FMRP) and metabotropic glutamate receptor subtype 5 (mGlu5) control stress granule formation in astrocytes
    Di Marco, B.
    Dell'Albani, P.
    D'Antoni, S.
    Spatuzza, M.
    Bonaccorso, C. M.
    Musumeci, S. A.
    Drago, F.
    Bardoni, B.
    Catania, M. V.
    NEUROBIOLOGY OF DISEASE, 2021, 154
  • [29] Mechanistic relationships between Drosophila fragile X mental retardation protein and metabotropic glutamate receptor A signaling
    Pan, Luyuan
    Woodruff, Elvin, III
    Liang, Ping
    Broadie, Kendal
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2008, 37 (04) : 747 - 760
  • [30] Group I metabotropic glutamate receptor-mediated long term depression is disrupted in the hippocampus of WAG/Rij rats modelling absence epilepsy
    Di Cicco, Gabriele
    Marzano, Emanuela
    Iacovelli, Luisa
    Celli, Roberta
    van Luijtelaar, Gilles
    Nicoletti, Ferdinando
    Ngomba, Richard T.
    Wall, Mark J.
    NEUROPHARMACOLOGY, 2021, 196